Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
MrWhy.com » Videos » Prof Christopher Twelves; Leeds Institute of Molecular Medicine and St. James’s Institute of Oncology, Leeds, UK
Prof Christopher Twelves; Leeds Institute of Molecular Medicine and St. James’s Institute of Oncology, Leeds, UK
Prof Christopher Twelves; Leeds Institute of Molecular Medicine and St. James’s Institute of Oncology,  Leeds, UK
Report
Prof Christopher Twelves; Leeds Institute of Molecular Medicine and St. James’s Institute of Oncology, Leeds, UK
Prof Christopher Twelves, speaking at the 2010 ASCO conference: A Phase III randomised trial finds that a new chemotherapy agent, eribulin mesylate, extends median overall survival by 2.5 months among women with locally recurrent or metastatic breast cancer who had already been heavily treated with conventional therapies.
Channel: www.ecancer.tv
Category: Science
Video Length: 0
Date Found: June 11, 2010
Date Produced:
View Count: 0
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.